A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy - Kidney International
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction | NEJM
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial | JACC: Heart Failure
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials - The Lancet Diabetes & Endocrinology
JFP - Diabetes Volume 68, No. 01
Dapagliflozin Reduces Heart Failure Worsening and Death in DAPA-HF Sub-analysis | DAIC
Dapagliflozin in Heart Failure | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og:image" content="https ...
Visual Abstract | DAPA-HF - American College of Cardiology
Dapagliflozin in Real World - ppt download
Efficacy data summary from the main phase 3 clinical trials of... | Download Table
Forxiga (dapagliflozin) for Treatment of Type 2 Diabetes - Clinical Trials Arena
DECLARE-TIMI 58 – TIMI STUDY GROUP
View of Dapagliflozin: Clinical practice compared with pre-registration trial data | British Journal of Diabetes
Outcomes in clinical trials compared with real-world data in patients... | Download Table
DAPA ACT HF-TIMI 68 – TIMI STUDY GROUP
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver? | SpringerLink
Efficacy results of randomized clinical trials with dapagliflozin... | Download Table
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions - ScienceDirect
ABCD - nationwide dapagliflozin audit
Selected Clinical Trials of SGLT2 inhibitors in CVD ... | GrepMed
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial - ScienceDirect
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial | Nature Medicine
Dapagliflozin helps reduce HbA1c and body weight in patients with type 2 diabetes as part of triple combination therapy: a subanalysis of four clinical studies - Virtual Meeting | EASD
